Vertical Peak Holdings Inc (SPLIF)
0.004
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Vertical Peak Holdings Cash from Financing (TTM): 0.0035M for April 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
April 30, 2023 | 0.0035M |
January 31, 2023 | 1.039M |
October 31, 2022 | 0.7726M |
July 31, 2022 | 0.8257M |
April 30, 2022 | 0.5485M |
January 31, 2022 | -0.2889M |
October 31, 2021 | -0.039M |
July 31, 2021 | -0.0246M |
April 30, 2021 | 0.3709M |
January 31, 2021 | 0.1906M |
October 31, 2020 | -0.0211M |
July 31, 2020 | 0.4385M |
April 30, 2020 | 4.523M |
January 31, 2020 | 5.032M |
October 31, 2019 | 5.928M |
July 31, 2019 | 8.196M |
April 30, 2019 | 3.906M |
Date | Value |
---|---|
January 31, 2019 | 10.12M |
October 31, 2018 | 12.00M |
July 31, 2018 | 9.280M |
April 30, 2018 | 9.553M |
January 31, 2018 | 3.388M |
October 31, 2017 | 5.198M |
July 31, 2017 | 6.909M |
April 30, 2017 | 6.550M |
January 31, 2017 | 6.772M |
October 31, 2016 | 2.901M |
July 31, 2016 | 1.228M |
April 30, 2016 | 1.191M |
January 31, 2016 | 1.746M |
October 31, 2015 | 1.758M |
July 31, 2015 | 1.872M |
April 30, 2015 | 2.695M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.2889M
Minimum
Jan 2022
8.196M
Maximum
Jul 2019
1.847M
Average
0.5485M
Median
Apr 2022
Cash from Financing (TTM) Benchmarks
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |
Edesa Biotech Inc | 2.224M |
Lexaria Bioscience Corp | 6.862M |
Xenon Pharmaceuticals Inc | 353.52M |